Cancer Innovation is a high-quality, peer-reviewed, open access journal covering key topics in all aspects of cancer research, focusing on emerging interdisciplinary, strategic frontiers and key common technologies in oncology.

A new frontier in innovative oncology solutions. Cancer Innovation provides timely updates on advances and unmet needs, bringing innovative oncology solutions to life.

Presenting a unique combination of oncology research, innovation, and data. Cancer Innovation bridges the gap between biological, medical, engineering, computational and data sciences. Its integrated, multidisciplinary coverage supports progress from basic research to clinical translation.

A hub for collaboration and communication across disciplines. Cancer Innovation unites researchers and clinicians from diverse medical subspecialities, providing opportunities to exchange, collaborate, and explore together.

A high-quality platform for guidelines on clinical decisions. Led by the China National Cancer Center, the editors ensure authentic statistics, consensus, and guidelines for clinical reference. Cancer Innovation combines professional resources to close the shortcomings in the management of oncological comorbidities.

Cancer Innovation is a high-quality peer-reviewed open access journal covering key topics in all aspects of cancer research, focusing on emerging interdisciplinary, strategic frontiers and key common technologies in oncology. The journal is dedicated to publishing innovative and significant research results in basic research and clinical oncology, including novel antitumor drugs, especially clinical trials with genetic/molecular signature data, big data-driven research on intelligent tumor diagnosis and treatment, interdisciplinary oncology innovation research and clinical translation in engineering, informatics, pharmacology, and biology. It also includes multidisciplinary oncology research and clinical translation of oncology and other medical subspecialties, such as cardiology, neurology, respiratory medicine, fertility and other interdisciplinary integration research and co-morbidity management, and also new viewpoints, new ideas, new methods and new models of cancer prevention, diagnosis, treatment and management.

The journal focuses on the development of carcinogenesis, basic science, clinical research, and translational applications in tumor prevention and precision diagnosis and treatment, aiming to provide authoritative references and best information for oncology-related researchers, promote the development of the field of oncology, and guide innovation and medical transformation. We sincerely welcome and accept insights and discussions from oncology scholars and experts worldwide.

Cancer Innovation covers the following 8 academic sections: Basic Cancer Research, Clinical Cancer Research, Oncological Pharmacology, Oncologic Imaging, Cancer Genomics, Cancer Informatics, Artificial Intelligence Application, and Lung Cancer.

Cancer Innovation covers the following 8 academic sections:
1. Basic Cancer Research
2. Clinical Cancer Research
3. Oncological Pharmacology
4. Oncologic Imaging
S. Cancer Genomics
6. Cancer Informatics
7. Artificial Intelligence Application
8. Lung Cancer

Oncologists and clinicians in related interdisciplinary fields

Researchers and practitioners in interdisciplinary medicine

Researchers in basic and translational medicine

Industrial researchers and developers of innovative oncology drugs and devices

Oncology, Interdisciplinary combination of medical and engineering sciences, Tumorigenesis, Diagnosis and Treatment of Tumor Progression, Clinical Trials, Onco-Cardiology, Onco-Pulmology, Onco-Neurology, Onco-Nephrology, Fertility Preservation, Translational Medicine, Quantum Mechanics, Computational Science, Big Data, Artificial Intelligence, Tumor Multiomics

Established in 1980, Tsinghua University Press (TUP) is a first-class national publisher and a leader in China’s academic and higher education publishing. It publishes about 2,500 new titles in print and digital format every year and dozens of Chinese and English journals. It enjoys high prestige both in China and around the world through close collaboration with hundreds of renowned publishers. In the era of new media, it is committed to rebuild itself as a comprehensive service provider of educational content.

Boao Cancer Institute (BIC) was founded on September 22, 2020, with the commitment to serve cancer science and technology. Believing in the idea of innovation-driven development and a healthy mind, this institute aims to promote health and well-being of the masses. As cancer is becoming a chronic disease, the new emphasis on "all-round and full-cycle" health management for cancer patient will support longer and better life.